Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$89.78

1.68 (1.91%)

07:55
04/13/19
04/13
07:55
04/13/19
07:55

Alnylam to hold a conference call

In conjunction with the Givosiran Phase 3 data being presented at the EASL 54th Annual International Liver Congress, management holds a conference call to discuss the presentation on April 13 at 8 am. Webcast Link

  • 13

    Apr

  • 25

    Apr

ALNY Alnylam
$89.78

1.68 (1.91%)

04/11/19
EVER
04/11/19
INITIATION
Target $120
EVER
Outperform
Alnylam initiated with an Outperform at Evercore ISI
Evercore ISI analyst Ravi Mehrotra initiated Alnylam with an Outperform rating and a price targets of $120, citing the "strength of its Onpattro franchise and high modality modularity." The analyst contends that the company's modular platform enables its "sustainable growth opportunities", points to its Lumasiran Phase 3 results being a "resounding win", and also notes that all of the company's pipeline segments are advancing.
04/09/19
LEER
04/09/19
NO CHANGE
Target $70
LEER
Market Perform
Alnylam price target raised to $70 from $65 at SVB Leerink
SVB Leerink analyst Mani Foroohar raised his price target for Alnylam (ALNY) to $70 from $65 after the company announced a collaboration with Regeneron (REGN) to develop and commercialize RNAi therapeutics with a focus on CNS and ocular indications, along with liver-directed NASH therapies and cemdisiran in combination with pozelimab. The analyst believes the terms of the deal, which includes a $400M upfront payment and a $400M equity investment in Alnylam at $90/share, are favorable for Alnylam. Foroohar reiterates a Market Perform rating on Alnylam's shares.
04/09/19
BMOC
04/09/19
NO CHANGE
Target $119
BMOC
Outperform
Alnylam price target raised to $119 from $106 at BMO Capital
BMO Capital analyst Do Kim raised his price target on Alnylam (ALNY) to $119 and kept his Outperform rating after its announced Regeneron (REGN) partnership on ocular / CNS diseases and liver-related diseases. The analyst expects the collaboration to result in favorable economics that also gives Alnylam an opportunity to co-promote its CNS program, but warns that some pressure on the stock is possible since the equity investment component by Regeneron at $90 per share was $3 below Friday's close.
04/08/19
PIPR
04/08/19
NO CHANGE
Target $142
PIPR
Overweight
Alnylam alliance with Regeneron a 'clear positive,' says Piper Jaffray
Alnylam Pharmaceuticals (ALNY) today concluded its 2014 RNAi discovery collaboration with Sanofi (SNY) and announced a new five-year RNAi drug discovery alliance with Regeneron Pharmaceuticals (REGN), Piper Jaffray analyst Edward Tenthoff tells investors in a research note. Alnylam will receive $400M in cash and Regeneron will make a $400M equity investment at $90 per Alnylam share, bringing its estimated pro forma cash to $2.3B, adds the analyst. He believes the alliance is a "clear positive for Alnylam "dramatically expanding" its RNAi drug discovery capabilities and strengthening its balance sheet to advance its own orphan disease programs. Tenthoff reiterates an Overweight rating on Alnylam with a $142 price target. The stock in early trading is down 3%, or $2.95, to $89.94.

TODAY'S FREE FLY STORIES

MMM

3M

$195.01

-24.23 (-11.05%)

12:18
04/25/19
04/25
12:18
04/25/19
12:18
Hot Stocks
JPMorgan's Tusa says 'no way' 3M can be broken up »

JPMorgan analyst Stephen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
04/25/19
04/25
12:17
04/25/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$195.20

-24.04 (-10.97%)

12:16
04/25/19
04/25
12:16
04/25/19
12:16
Hot Stocks
JPMorgan's Tusa stands by $154 price target on 3M »

JPMorgan analyst Stephen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
04/25/19
04/25
12:16
04/25/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$195.55

-23.69 (-10.81%)

, HON

Honeywell

$170.63

-0.63 (-0.37%)

12:15
04/25/19
04/25
12:15
04/25/19
12:15
Hot Stocks
JPMorgan's Tusa says 3M should trade at discount to Honeywell »

JPMorgan analyst Stephen…

MMM

3M

$195.55

-23.69 (-10.81%)

HON

Honeywell

$170.63

-0.63 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 14

    May

  • 14

    May

  • 18

    May

  • 29

    May

MMM

3M

$195.61

-23.63 (-10.78%)

12:14
04/25/19
04/25
12:14
04/25/19
12:14
Hot Stocks
JPMorgan's Tusa says 3M neither 'growthy' nor 'defensive' »

JPMorgan analyst Stephen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

MAS

Masco

$38.51

-1.47 (-3.68%)

12:10
04/25/19
04/25
12:10
04/25/19
12:10
Options
3K Masco May 37 - 39 put spreads sold at 83c »

3K Masco May 37 - 39 put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

NITE

Nightstar Therapeutics

$25.54

0.01 (0.04%)

, BIIB

Biogen

$230.56

6.24 (2.78%)

12:07
04/25/19
04/25
12:07
04/25/19
12:07
Hot Stocks
Polygon discloses 7.97% stake in Nightstar, sends letters to board »

Polygon Global Partners…

NITE

Nightstar Therapeutics

$25.54

0.01 (0.04%)

BIIB

Biogen

$230.56

6.24 (2.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 04

    May

  • 29

    May

FNB

F.N.B.

$11.99

0.01 (0.08%)

12:04
04/25/19
04/25
12:04
04/25/19
12:04
Hot Stocks
First National Bank appoints Samuel Kirsch as chief digitial officer »

First National Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

CRC

California Resources

$22.75

-3.55 (-13.50%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
California Resources falls -13.4% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 08

    May

HZO

MarineMax

$16.59

-3.255 (-16.41%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
MarineMax falls -16.3% »

MarineMax is down -16.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CLS

Celestica

$7.19

-1.42 (-16.50%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Celestica falls -16.7% »

Celestica is down -16.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

AAN

Aaron's

$58.07

4.745 (8.90%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Aaron's rises 9.0% »

Aaron's is up 9.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 13

    Nov

WAB

Wabtec

$71.90

-4.67 (-6.10%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Options
Downside put buy in Wabtec as shares wobble after earnings »

Downside put buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

  • 13

    Nov

OIS

Oil States

$20.53

2.11 (11.45%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Oil States rises 12.4% »

Oil States is up 12.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

ASPN

Aspen Aerogels

$3.56

0.36 (11.25%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Aspen Aerogels rises 12.7% »

Aspen Aerogels is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 28

    May

NWL

Newell Brands

$13.84

-0.4 (-2.81%)

11:55
04/25/19
04/25
11:55
04/25/19
11:55
Options
Newell Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 07

    May

  • 14

    May

  • 15

    May

  • 16

    May

  • 17

    May

11:50
04/25/19
04/25
11:50
04/25/19
11:50
General news
U.S. Treasury tax receipts continue to surge »

U.S. Treasury tax…

GILD

Gilead

$63.57

0.75 (1.19%)

11:48
04/25/19
04/25
11:48
04/25/19
11:48
Recommendations
Gilead analyst commentary at Piper Jaffray »

Piper Jaffray 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 06

    May

  • 08

    May

  • 18

    May

IMMR

Immersion

$9.27

0.03 (0.32%)

11:45
04/25/19
04/25
11:45
04/25/19
11:45
Options
Immersion call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
04/25/19
04/25
11:45
04/25/19
11:45
General news
Treasury's $85 B 4- and 8-week bill auctions were mixed »

Treasury's $85 B 4-…

11:43
04/25/19
04/25
11:43
04/25/19
11:43
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

11:43
04/25/19
04/25
11:43
04/25/19
11:43
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

FB

Facebook

$193.51

10.87 (5.95%)

, TSLA

Tesla

$251.50

-7.2 (-2.78%)

11:38
04/25/19
04/25
11:38
04/25/19
11:38
On The Fly
Facebook upgrade, Tesla downgrade among today's top calls »

Check out today's top…

FB

Facebook

$193.51

10.87 (5.95%)

TSLA

Tesla

$251.50

-7.2 (-2.78%)

PTC

PTC

$90.78

-11.16 (-10.95%)

XLNX

Xilinx

$116.64

-23.15 (-16.56%)

GD

General Dynamics

$178.46

-2.21 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 01

    May

  • 14

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

PAGS

PagSeguro Digital

$26.34

-0.14 (-0.53%)

11:35
04/25/19
04/25
11:35
04/25/19
11:35
Options
PagSeguro Digital put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.